MusclePharm Corporation Retained Earnings
MusclePharm Corporation had Retained Earnings of -$211.84 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-05-16
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$211.84M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$205.54M.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$198.76M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$194.83M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2022-03-31 | -$211.84M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$205.54M 10-Q · filed 2022-05-16 | |
| 2021-09-30 | -$198.76M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | -$194.83M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$192.58M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | -$192.67M 10-K/A · filed 2022-05-04 | |
| 2020-09-30 | -$195.49M 10-Q · filed 2020-11-24 | |
| 2020-06-30 | -$196.17M 10-Q · filed 2020-11-24 | |
| 2020-03-31 | -$195.92M 10-Q · filed 2020-11-24 | |
| 2019-12-31 | -$195.86M 10-K · filed 2021-03-29 | |
| 2019-09-30 | -$192.40M 10-Q · filed 2020-08-25 | |
| 2019-06-30 | -$187.32M 10-Q · filed 2020-08-25 | |
| 2019-03-31 | -$181.44M 10-Q · filed 2020-08-25 | |
| 2018-12-31 | -$176.88M 10-Q · filed 2020-08-25 | |
| 2018-09-30 | -$170.34M 10-Q · filed 2020-08-25 | -$167.32M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$168.91M 10-Q · filed 2020-08-25 | -$165.34M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$168.63M 10-Q · filed 2020-08-25 | -$164.27M 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$165.07M 10-K · filed 2020-08-25 | -$161.97M 10-K · filed 2018-04-02 |
| 2017-09-30 | -$159.42M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$157.29M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$154.14M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$152.56M 10-K · filed 2020-08-25 | -$150.99M 10-K · filed 2017-03-15 |
| 2016-09-30 | -$159.76M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$158.32M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$154.12M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$147.52M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$137.81M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$110.16M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$103.14M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$95.66M 10-K · filed 2017-03-15 | |
| 2014-09-30 | -$79.42M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$80.03M 10-Q · filed 2014-10-31 | -$78.68M 10-Q · filed 2014-08-05 |
| 2014-03-31 | -$79.09M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | -$81.83M 10-K · filed 2015-03-16 | -$81.83M 10-K · filed 2014-03-31 |
| 2013-09-30 | -$77.84M 10-Q/A · filed 2014-01-13 | |
| 2013-06-30 | -$73.89M 10-Q/A · filed 2014-01-13 | |
| 2013-03-31 | -$71.47M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$64.11M 10-K · filed 2014-03-31 | |
| 2012-09-30 | -$61.08M 10-Q/A · filed 2012-11-16 | |
| 2012-06-30 | -$55.01M 10-Q/A · filed 2012-09-13 | |
| 2012-03-31 | -$61.19M 10-Q/A · filed 2012-05-29 | |
| 2011-12-31 | -$45.16M 10-K · filed 2013-04-01 | |
| 2011-09-30 | -$34.21M 10-Q/A · filed 2012-07-09 | |
| 2011-06-30 | -$34.32M 10-Q/A · filed 2012-07-13 | |
| 2010-12-31 | -$21.88M 10-Q/A · filed 2012-07-13 | |
| 2009-12-31 | -$2.31M 10-K/A · filed 2011-09-27 |